CDKN2A and carcinoma: Using a spatiotemporally controlled in vivo system targeting genomic alterations to a single pool of epithelial progenitor cells, we show that unrestrained YAP activation in the context of HPV oncoprotein-mediated TP53 and CDKN2A inhibition induces carcinoma with rapid kinetics and high penetrance.